A Prospective Randomized, Blinded Parallel Group Study of Clotrimazole Troches vs. Mycelex® Troches (10 mg Troche Five Times a Day for 14 Days) in Patients With Human Insufficiency Virus (HIV) Infection for the Treatment of Oropharyngeal Candidiasis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2001
Drug: Roxanes's clotrimazole troches;Drug: Mycelex® troches Percent of patients that have a clinical response assessed by symptoms and physical examination Incidence of negative fungal cultures of the oropharynx for Candida species;Incidence of negative fungal cultures of the oropharynx for Candida species;Clinical response by symptom assessment and physical examination;Assessment of compliance with Treatment by troche Count and Patient interview
Epistemonikos ID: 101c607b917110af3df40034d00dc535b926baaa
First added on: Mar 23, 2020